Acute Coronary Syndrome, Tobacco Use
Conditions
Keywords
smoking, depression, Behavioral Activation
Brief summary
Quitting smoking following acute coronary syndrome can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R56 the investigators will conduct a vanguard trial to pilot all methods, materials, and systems for the later fully powered BAT-CS vs. attention control trial. The investigators will enroll up to 36 smokers with ACS and randomize them to 12 weeks of BAT-CS or an attention control (Health and Wellness Education). Both groups will be offered the nicotine patch if medically safe.
Interventions
BEHAVIORALExperimental: Behavioral Activation Treatment for Cardiac Smokers (BAT-CS)
All participants will receive one hour of standard smoking cessation counseling during their hospitalization for an acute coronary syndrome. Participants will be randomized 1 week after discharge. Those assigned to BAT-CS condition will receive 5 more counseling sessions over the 12 weeks after discharge. The first will be up to one hour and will be conducted in person. The next 4 sessions will occur by phone and will take about 30 minutes. Post-discharge sessions will be focused on smoking cessation and mood management using behavioral activation techniques. Participants will be offered the nicotine patch if medically cleared.
BEHAVIORALSmoking cessation plus Health and Wellness
All participants will receive one hour of standard smoking cessation counseling during their hospitalization for an acute coronary syndrome. Participants will be randomized 1 week after discharge. Those assigned to the Smoking cessation plus Health and Wellness condition will receive 5 more counseling sessions over the 12 weeks after hospital discharge. The first will be up to one hour and will be conducted in person. The next 4 sessions will occur over the phone and will take about 30 minutes. Post-discharge sessions will be focused on smoking cessation and didactic health and wellness education. Participants will be offered the nicotine patch if medically cleared.
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
The Miriam Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. hospital inpatients with an ACS diagnosis documented in medical record, 2. smoked 1 or more cigarettes per day before being hospitalized, 3. age of 18-75, 4. English fluency, 5. lives within a 1 hour drive of the admitting hospital and has no plans to move away from the area for 1 year, 6. willing to consider quitting smoking at discharge, 7. has telephone, and 8. willing to consent to all study procedures.
Exclusion criteria
1. limited mental competency (i.e., Mini Mental Status Exam score ≤ 23); 2. presence of severe mental illness that would interfere with participation (e.g., schizophrenia) or suicidality; 3. expected discharge to hospice; and 4. currently attending counseling for depression or smoking cessation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Treatment Acceptability | 12 weeks post-Discharge | Treatment Acceptability as measured by the Client Satisfaction Questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Smoking Cessation | 12 weeks post-Discharge | 7 day point-prevalence abstinence. Biochemically verified. |
| Depression Symptoms | 12 weeks post-Discharge | Depression Symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9) |
Countries
United States
Outcome results
None listed